110 related articles for article (PubMed ID: 340723)
1. [Absorption and excretion, and clinical study of sustained release cephalexin (S-6437) in children (author's transl)].
Motohiro T; Sakata Y; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F
Jpn J Antibiot; 1977 Dec; 30(12):961-72. PubMed ID: 340723
[No Abstract] [Full Text] [Related]
2. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)].
Saito K; Ubukata K; Konno M
Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187
[TBL] [Abstract][Full Text] [Related]
3. [Study of S-6437 (sustained release cephalexin) in pediatrics (author's transl)].
Iwai N; Suzuki C; Maki T; Tauchi N; Kawamura M
Jpn J Antibiot; 1977 Sep; 30(9):710-21. PubMed ID: 916192
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and pharmacological evaluation of S-6436 (long acting preparation of cephalexin) in urinary tract infections (author's transl)].
Takamoto H; Kamata H; Hirano M; Niijima T; Onoda T
Kansenshogaku Zasshi; 1977 Jun; 51(6):343-52. PubMed ID: 411848
[No Abstract] [Full Text] [Related]
5. [Clinical experience with sustained release cephalexin (S-6437) in pediatrics (author's transl)].
Hori M; Okamoto K; Kohno S
Jpn J Antibiot; 1978 Feb; 31(2):59-71. PubMed ID: 642208
[TBL] [Abstract][Full Text] [Related]
6. [Sensitivity of bacteria inducing urinary infections to 3 drugs (amoxicillin, ampicillin and cephalexin) and clinical efficacy of amoxicillin (author's transl)].
Fukushima S; Fujii H; Kitajima N; Suzuki M
Jpn J Antibiot; 1975 Dec; 28(6):795-801. PubMed ID: 1104914
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of sustained release cephalexin (S-6435 and S-6436) in tonsillitis and pharyngitis (author's transl)].
Kubo N
Jpn J Antibiot; 1977 Nov; 30(11):906-10. PubMed ID: 592492
[TBL] [Abstract][Full Text] [Related]
8. [Study of S-6437, sustained release cephalexin, in pediatrics (author's transl)].
Sato H; Fujii N; Shinnou K; Kojima S; Hirama Y
Jpn J Antibiot; 1977 Sep; 30(9):684-90. PubMed ID: 916189
[No Abstract] [Full Text] [Related]
9. [Clinical study of sustained release cephalexin (S-6436, S-6437) in dermatology (author's transl)].
Okita K; Sato M; Hayakawa K; Kimura K
Jpn J Antibiot; 1977 Nov; 30(11):911-5. PubMed ID: 592493
[TBL] [Abstract][Full Text] [Related]
10. [Fundamental and clinical studies of S-6437 in children (author's transl)].
Kobayashi Y; Morikawa Y; Haruta T; Yoshioka N
Jpn J Antibiot; 1977 Sep; 30(9):729-37. PubMed ID: 916194
[No Abstract] [Full Text] [Related]
11. [Clinical experience with S-6436 in patients with urinary tract infections (author's transl)].
Urata H; Komeda K; Tochigi H; Morishita F; Horiuchi E
Jpn J Antibiot; 1977 Oct; 30(10):829-34. PubMed ID: 338939
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with sustained release cephalexin (S-6436) in urology (author's transl)].
Konya H; Kuroda J; Iwao N
Jpn J Antibiot; 1977 Nov; 30(11):898-905. PubMed ID: 592491
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)].
Kondo K; Kuno K; Koide T; Fukaya K; Jose H
Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with sustained release cefalexin (S-6436) in surgery (author's transl)].
Takenaka M; Tanimura H; Kamata T; Setoyama M
Jpn J Antibiot; 1977 Nov; 30(11):893-7. PubMed ID: 592490
[TBL] [Abstract][Full Text] [Related]
15. [Clinical experience with sustained release cephalexin (X-6437) (author's transl)].
Kato R; Asano Y; Tsuzuki K; Iwayama S; Ito S
Jpn J Antibiot; 1977 Nov; 30(11):888-92. PubMed ID: 592489
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological and clinical studies on S-6436 in urinary tract infections (author's transl)].
Ishigami J; Tanikaze S; Kataoka N; Yamaguchi K; Mita T
Kansenshogaku Zasshi; 1977 Jun; 51(6):335-42. PubMed ID: 411847
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of urinary tract infections in children and standards for evaluating its efficacy--with special reference to the therapeutic results of cephalexin suspensions].
Kobayashi Y; Akaishi K; Nishio T; Goto K; Aihara M
Jpn J Antibiot; 1972 Apr; 25(2):104-19. PubMed ID: 4561052
[No Abstract] [Full Text] [Related]
18. [The effect of the combination of cephalexin with tobramycin on experimental pyelonephritis (author's transl)].
Hatala M; Morávek J; Liska M; Modr Z; Prát V
Cas Lek Cesk; 1976 May; 115(20-21):619-22. PubMed ID: 1277247
[No Abstract] [Full Text] [Related]
19. [Fundamental and clinical studies on S-6436 (author's transl)].
Nasu M; Nakatomi M; Hirota M; Nagasawa T; Horiuchi N
Kansenshogaku Zasshi; 1977 Jul; 51(7):371-6. PubMed ID: 411852
[No Abstract] [Full Text] [Related]
20. [Clinical studies of S-6437 in pediatrics (author's transl)].
Nishimura T; Kotani Y; Hiromatsu K; Takashima T; Asatani Y
Jpn J Antibiot; 1977 Sep; 30(9):722-8. PubMed ID: 916193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
